Your browser doesn't support javascript.
loading
Psilocybin-assisted therapy for the treatment of resistant major depressive disorder (PsiDeR): protocol for a randomised, placebo-controlled feasibility trial.
Rucker, James; Jafari, Hassan; Mantingh, Tim; Bird, Catherine; Modlin, Nadav Liam; Knight, Gemma; Reinholdt, Frederick; Day, Camilla; Carter, Ben; Young, Allan.
Afiliação
  • Rucker J; Department of Psychological Medicine, King's College London, London, UK james.rucker@kcl.ac.uk.
  • Jafari H; National Affective Disorders Service, South London and Maudsley NHS Foundation Trust, London, UK.
  • Mantingh T; Department of Biostatistics, King's College London, London, UK.
  • Bird C; Department of Psychological Medicine, King's College London, London, UK.
  • Modlin NL; Department of Psychological Medicine, King's College London, London, UK.
  • Knight G; Department of Psychological Medicine, King's College London, London, UK.
  • Reinholdt F; Department of Psychological Medicine, King's College London, London, UK.
  • Day C; Department of Psychological Medicine, King's College London, London, UK.
  • Carter B; Department of Psychological Medicine, King's College London, London, UK.
  • Young A; National Affective Disorders Service, South London and Maudsley NHS Foundation Trust, London, UK.
BMJ Open ; 11(12): e056091, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34853114
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article